Creative biogene
SHARE THIS
facebook twitterlinkedingoogle plusStumbleUpon blog


Human ADORA2B/beta-Arrestin Stable Cell Line-CHO

See other products for ADORA2B
Cat.No.
CSC-RG1402
Background
A2B is a receptor for adenosine. A2B receptor is upregulated during intestinal inflammation and mediates key events such as chloride, IL-6 and fibronectin secretion in intestinal epithelial cells. A2B receptor antagonists may have important clinical value in the treatment of inflammatory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), as well as inflammatory bowel disease.
Growth Properties
Adherent
Morphology
Epithelial-like
Host Cell
CHO-K1
Ship
Dry ice
Gene Information
Official Symbol
ADORA2B
Synonyms
ADORA2B; adenosine A2b receptor; adenosine receptor A2b; ADORA2;
Gene ID
MIM
UniProt ID
P29275
Chromosome Location
17p12
Pathway
Adenosine P1 receptors, organism-specific biosystem; C-MYB transcription factor network, organism-specific biosystem; Calcium signaling pathway, organism-specific biosystem; Calcium signaling pathway, conserved biosystem; Class A/1 (Rhodopsin-like receptors), organism-specific biosystem; G alpha (s) signalling events, organism-specific biosystem; GPCR downstream signaling, organism-specific biosystem;
Function
G-protein coupled adenosine receptor activity; receptor activity; signal transducer activity;
Related Products
Cat#
Product Name
Host Cell
Gene Symbol
Species
Price
CSC-SC000320
HEK293 ,CHO, etc.
ADORA2B
Human
CSC-RG1717
HEK293T
ADORA2B
Rat
CSC-DC000320
HEK293 ,Hela, etc.
ADORA2B
Human
CSC-RG0167
HEK293T
ADORA2B
Human
CSC-RG0466
CHO-K1
ADORA2B
Human
Cat#
Product Name
Titer
Product Size
Species
Price
AD00722Z
>1x 10^9 vp/ml
1 x 0.2 ml
Human

Related Services

Quick Inquiry

Please input "biogene" as verification code.

CONTACT CREATIVE BIOGENE

45-1 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-626-9181
Fax: 1-631-614-7828
Email: info@creative-biogene.com

Europe
Tel: 44-207-097-1828

Terms & Conditions | Privacy Policy | Sitemap | FAQ | © 2010-2018 Creative Biogene. All Rights Reserved.